The disease-modifying therapy utilisation and cost trend for multiple sclerosis in Australia between 2013 and 2022. Zhao T, Taylor BV, Campbell JA, Palmer AJ, et al. Mult Scler 2023 Nov 24:13524585231213230. doi: 10.1177/13524585231213230.

Read + Share

Amedeo Smart

Independent Medical Education

Zhao T, Taylor BV, Campbell JA, Palmer AJ, et al. The disease-modifying therapy utilisation and cost trend for multiple sclerosis in Australia between 2013 and 2022. Mult Scler 2023 Nov 24:13524585231213230. doi: 10.1177/13524585231213230.
PMID: 38116594